Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: High Pressure Liquid Chromatography Users (US)(?)

Council Members in this Study Group: 38

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)
Managing Principal
The Compass Group, Scarborough

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a confederation of 18...

B. Michael Silber, PHD, Chief of Drug Discovery R&D and Adjunct Professor, UNIVERSITY OF CALIFORNIA, SAN FRANCISCOB. Michael Silber, PHD
Chief of Drug Discovery R&D and Adjunct Professor
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Michael Silber, PhD, is Chief of Drug Discovery R & D and Adjunct Professor of Neurology and Biopharmaceutical Sciences, Institute for Neurodegenerative Diseases, at UCSF Medical School. He has over 25 years of expertise in all aspects of Pharma and Biotech R & D and API and biologics manufacturing,...

Most Common Company Types:

  • Pharmaceuticals Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Biotechnology Manufacturer
  • Academic Institution*
  • Lab, Academic Medical Center
  • Pharmaceuticals/Biotechnology Research Services

Most Common Job Types:

  • Research Scientist
  • Director
  • President
  • Professor
  • Quality Control Supervisor
  • Physician - Director
  • Chemist
  • Physician - Department Chair
  • Researcher

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-06T21:45:17.077